Journal Article

DKFZ-2022-00766

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Circulating inflammatory biomarkers, adipokines and breast cancer risk-a case-control study nested within the EPIC cohort.

Cairat, M. ; Rinaldi, S. ; Navionis, A.-S. ; Romieu, I. ; Biessy, C. ; Viallon, V. ; Olsen, A. ; Tjønneland, A. ; Fournier, A. ; Severi, G. ; Kvaskoff, M. ; Fortner, R. T.DKFZ* ; Kaaks, R.DKFZ* ; Aleksandrova, K. ; Schulze, M. B. ; Masala, G. ; Tumino, R. ; Sieri, S. ; Grasso, C. ; Mattiello, A. ; Gram, I. T. ; Olsen, K. S. ; Agudo, A. ; Etxezarreta, P. A. ; Sánchez, M.-J. ; Santiuste, C. ; Barricarte, A. ; Monninkhof, E. ; Hiensch, A. E. ; Muller, D. ; Merritt, M. A. ; Travis, R. C. ; Weiderpass, E. ; Gunter, M. J. ; Dossus, L.

2022
Springer Heidelberg [u.a.]

This record in other databases:  

Please use a persistent id in citations: doi:10.1186/s12916-022-02319-y

Abstract: Inflammation has been hypothesized to play a role in the development and progression of breast cancer and might differently impact breast cancer risk among pre and postmenopausal women. We performed a nested case-control study to examine whether pre-diagnostic circulating concentrations of adiponectin, leptin, c-reactive protein (CRP), tumour necrosis factor-α, interferon-γ and 6 interleukins were associated with breast cancer risk, overall and by menopausal status.Pre-diagnostic levels of inflammatory biomarkers were measured in plasma from 1558 case-control pairs from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. We used conditional logistic regression to estimate the odds ratios (ORs) of breast cancer at blood collection, per one standard deviation increase in biomarker concentration.Cases were diagnosed at a mean age of 61.4 years on average 8.6 years after blood collection. No statistically significant association was observed between inflammatory markers and breast cancer risk overall. In premenopausal women, borderline significant inverse associations were observed for leptin, leptin-to-adiponectin ratio and CRP [OR= 0.89 (0.77-1.03), OR= 0.88 (0.76-1.01) and OR= 0.87 (0.75-1.01), respectively] while positive associations were observed among postmenopausal women [OR= 1.16 (1.05-1.29), OR= 1.11 (1.01-1.23), OR= 1.10 (0.99-1.22), respectively]. Adjustment for BMI strengthened the estimates in premenopausal women [leptin: OR = 0.83 (0.68-1.00), leptin-to-adiponectin ratio: OR = 0.80 (0.66-0.97), CRP: OR = 0.85 (0.72-1.00)] but attenuated the estimates in postmenopausal women [leptin: OR = 1.09 (0.96-1.24), leptin-to-adiponectin ratio: OR = 1.02 (0.89-1.16), CRP: OR = 1.04 (0.92-1.16)].Associations between CRP, leptin and leptin-to-adiponectin ratio with breast cancer risk may represent the dual effect of obesity by menopausal status although this deserves further investigation.

Keyword(s): Adipokines (MeSH) ; Adiponectin (MeSH) ; Biomarkers (MeSH) ; Body Mass Index (MeSH) ; Breast Neoplasms: diagnosis (MeSH) ; Breast Neoplasms: epidemiology (MeSH) ; C-Reactive Protein: metabolism (MeSH) ; Case-Control Studies (MeSH) ; Female (MeSH) ; Humans (MeSH) ; Leptin (MeSH) ; Middle Aged (MeSH) ; Prospective Studies (MeSH) ; Risk Factors (MeSH) ; Anthropometry ; Biomarkers ; Breast cancer ; Inflammation ; Menopausal status ; Adipokines ; Adiponectin ; Biomarkers ; Leptin ; C-Reactive Protein

---

Contributing Institute(s):

1. C020 Epidemiologie von Krebs (C020)

Research Program(s):

1. 313 - Krebsrisikofaktoren und Prävention (POF4-313) (POF4-313)

Appears in the scientific report 2022

---

Database coverage:
; ; ; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF >= 10 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---